MYCN and neoplasm: While Hsp90 inhibitors have previously shown some activity in MB [13], Hsp70 represents a new target in MB, and neither of the Hsp90 and Hsp70 chaperones has previously been shown to be specific targets in N‐Myc‐driven tumour cells.